The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 26, 2017
Filed:
Nov. 20, 2013
Applicant:
Biogen MA Inc., Cambridge, MA (US);
Inventors:
Hairuo Peng, Cambridge, MA (US);
Zhili Xin, Cambridge, MA (US);
Lihong Sun, Cambridge, MA (US);
Timothy Chan, Cambridge, MA (US);
Gnanasambandam Kumaravel, Cambridge, MA (US);
Arthur G. Taveras, Cambridge, MA (US);
Assignee:
BIOGEN MA INC., Cambridge, MA (US);
Primary Examiner:
Int. Cl.
CPC ...
C07D 211/62 (2006.01); C07D 401/10 (2006.01); C07D 237/14 (2006.01); C07D 215/14 (2006.01); C07D 401/04 (2006.01); C07D 239/34 (2006.01); C07D 417/04 (2006.01); C07D 417/06 (2006.01); C07C 229/14 (2006.01); C07D 249/06 (2006.01); C07C 229/48 (2006.01); C07C 229/50 (2006.01); C07D 487/04 (2006.01); C07D 205/04 (2006.01); C07D 207/16 (2006.01); C07D 277/28 (2006.01); C07D 209/44 (2006.01); C07D 211/34 (2006.01); C07D 211/46 (2006.01); C07D 213/38 (2006.01); C07D 213/65 (2006.01); A61K 31/196 (2006.01); A61K 31/197 (2006.01); A61K 31/397 (2006.01); A61K 31/40 (2006.01); A61K 31/427 (2006.01); A61K 31/445 (2006.01); A61K 31/4545 (2006.01); A61K 31/50 (2006.01); A61K 31/505 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
C07D 211/62 (2013.01); A61K 31/196 (2013.01); A61K 31/197 (2013.01); A61K 31/397 (2013.01); A61K 31/40 (2013.01); A61K 31/427 (2013.01); A61K 31/445 (2013.01); A61K 31/4545 (2013.01); A61K 31/50 (2013.01); A61K 31/505 (2013.01); A61K 45/06 (2013.01); C07C 229/14 (2013.01); C07C 229/48 (2013.01); C07C 229/50 (2013.01); C07D 205/04 (2013.01); C07D 207/16 (2013.01); C07D 209/44 (2013.01); C07D 211/34 (2013.01); C07D 211/46 (2013.01); C07D 213/38 (2013.01); C07D 213/65 (2013.01); C07D 215/14 (2013.01); C07D 237/14 (2013.01); C07D 239/34 (2013.01); C07D 249/06 (2013.01); C07D 277/28 (2013.01); C07D 401/04 (2013.01); C07D 401/10 (2013.01); C07D 417/04 (2013.01); C07D 417/06 (2013.01); C07D 487/04 (2013.01); C07B 2200/07 (2013.01); C07C 2601/14 (2017.05); C07C 2602/44 (2017.05);
Abstract
Compounds of formula (I), and pharmaceutically acceptable salts thereof, can modulate the activity of one or more SIP receptors and/or the activity of autotaxin (ATX).